Cargando…
Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
Acute Myeloid Leukaemia is a devastating disease that continues to have a poor outcome for the majority of patients. In recent years, however, a number of drugs have received FDA approval, following on from successful clinical trial results. This parallels the characterization of the molecular lands...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895902/ https://www.ncbi.nlm.nih.gov/pubmed/31717784 http://dx.doi.org/10.3390/cancers11111660 |